Prosecution Insights
Prosecution Insights
Technology areas: Chemistry & Materials • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Immutrix Therapeutics Inc. currently has 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed across 2 distinct examiners, indicating that the workload is not concentrated under a single individual. This distribution suggests a diversified prosecution approach where different technical perspectives may be applied to the company's applications. This variety can provide multiple paths for portfolio development.
The busiest examiner identified in the data is TU, AURELIE H, who is responsible for 1 busiest examiner pending action. This represents exactly half of the total 2 pending office actions currently active for the portfolio. Because the actions are also split between 2 distinct art units, the prosecution strategy must account for different administrative standards and examination cultures within the Medical Devices & Mechanical Engineering sector.
For a practitioner, the presence of multiple examiners and art units for the pending workload means there is no central point of failure or success. The strategy for TU, AURELIE H may differ from the approach required for the other examiner. This lack of concentration requires the company to maintain a flexible prosecution style that adapts to the 1 busiest examiner pending action while managing the broader portfolio requirements across different units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| §112 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TU, AURELIE H | 1 | 56.4% | +60.0% |
| HENDRICKSON, STUART L | 1 | 72.3% | +8.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17284842 | ADSORPTION AND BINDING OF PLASMA MOLECULES AND PARTICLES TO CARBON | TU, AURELIE H | 23d overdue |
| Art Unit | Apps |
|---|---|
| 3791 | 1 |
| 1736 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17284842 | ADSORPTION AND BINDING OF PLASMA MOLECULES AND PARTICLES TO CARBON | TU, AURELIE H | 3791 | §112 | Non-Final OA | 23d overdue | Pending | Apr 13, 2021 |
| 16772969 | TAILORED POROSITY MATERIALS AND METHODS OF MAKING AND USING SAME | HENDRICKSON, STUART L | 1736 | §103Other | Final Rejection | 9d | Pending | Jun 15, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial